What is the clinical and cost effectiveness of telemonitoring and self-monitoring compared with usual care, in people with heart failure?
Telemonitoring (TM) and self-monitoring (SM) have been found to be clinically effective in improving clinical outcomes and cost effectiveness in people with heart failure (HF). TM and SM have been associated with improved quality of life, reduced hospital readmission rates, and improved survival in people with HF. Additionally, TM and SM have been found to be cost-effective compared to usual care, and have the potential to reduce healthcare costs in the long run.